GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International, Inc. (FRA:HIY1) » Definitions » Pretax Margin %

Heartware International, (FRA:HIY1) Pretax Margin % : -15.55% (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Heartware International, Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Heartware International,'s Pre-Tax Income for the three months ended in Jun. 2016 was €-9.5 Mil. Heartware International,'s Revenue for the three months ended in Jun. 2016 was €61.2 Mil. Therefore, Heartware International,'s pretax margin for the quarter that ended in Jun. 2016 was -15.55%.

The historical rank and industry rank for Heartware International,'s Pretax Margin % or its related term are showing as below:

FRA:HIY1' s Pretax Margin % Range Over the Past 10 Years
Min: -7157.83   Med: -59.91   Max: -6.75
Current: -22.71


FRA:HIY1's Pretax Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.535 vs FRA:HIY1: -22.71

Heartware International, Pretax Margin % Historical Data

The historical data trend for Heartware International,'s Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International, Pretax Margin % Chart

Heartware International, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.52 -79.08 -28.30 -6.75 -25.92

Heartware International, Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.82 -45.51 -1.06 -31.43 -15.55

Competitive Comparison of Heartware International,'s Pretax Margin %

For the Medical Devices subindustry, Heartware International,'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartware International,'s Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heartware International,'s Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Heartware International,'s Pretax Margin % falls into.



Heartware International, Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Heartware International,'s Pretax Margin for the fiscal year that ended in Dec. 2015 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-65.881/254.142
=-25.92 %

Heartware International,'s Pretax Margin for the quarter that ended in Jun. 2016 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2016 )/Revenue (Q: Jun. 2016 )
=-9.51/61.161
=-15.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heartware International,  (FRA:HIY1) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Heartware International, Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Heartware International,'s Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International, (FRA:HIY1) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Heartware International, (FRA:HIY1) Headlines

No Headlines